Activation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhibition

被引：0
|
作者：
Cedric Leroy
Pedro Ramos
Karen Cornille
Debora Bonenfant
Christine Fritsch
Hans Voshol
Mohamed Bentires-Alj
机构：
[1] Friedrich Miescher Institute for Biomedical Research,
[2] Novartis Institutes for Biomedical Research,undefined
来源：
Breast Cancer Research | / 18卷
关键词：
Phosphatidylinositol 3-kinase; p110α; p110β; Resistance; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Activation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhibition
    Leroy, Cedric
    Ramos, Pedro
    Cornille, Karen
    Bonenfant, Debora
    Fritsch, Christine
    Voshol, Hans
    Bentires-Alj, Mohamed
    [J]. BREAST CANCER RESEARCH, 2016, 18
  • [2] Differential Activation of MAPK and PI3K/AKT/mTOR Pathways and IGF1R Expression in Gastrointestinal Stromal Tumors
    Rios-Moreno, M. J.
    Jaramillo, S.
    Diaz-Delgado, M.
    Sanchez-Leon, M.
    Trigo-Sanchez, I.
    Polo Padillo, J.
    Amerigo, J.
    Gonzalez-Campora, R.
    [J]. ANTICANCER RESEARCH, 2011, 31 (09) : 3019 - 3025
  • [3] Enhanced PI3K p110α Signaling Confers Acquired Lapatinib Resistance That Can Be Effectively Reversed by a p110α-Selective PI3K Inhibitor
    Brady, Samuel W.
    Zhang, Jian
    Seok, Daniel
    Wang, Hai
    Yu, Dihua
    [J]. MOLECULAR CANCER THERAPEUTICS, 2014, 13 (01) : 60 - 70
  • [4] SMER28 Attenuates PI3K/mTOR Signaling by Direct Inhibition of PI3K p110 Delta
    Kirchenwitz, Marco
    Stahnke, Stephanie
    Prettin, Silvia
    Borowiak, Malgorzata
    Menke, Laura
    Sieben, Christian
    Birchmeier, Carmen
    Rottner, Klemens
    Stradal, Theresia E. B.
    Steffen, Anika
    [J]. CELLS, 2022, 11 (10)
  • [5] Combination of IGF1R/FAK inhibition and PI3K/mTOR inhibition in triple-negative breast cancers
    Taliaferro-Smith, LaTonia D.
    Liu, Tongrui
    Alcaide, Tiffanie Y.
    McGlothen, Tanisha Z.
    O'Regan, Ruth M.
    [J]. CANCER RESEARCH, 2015, 75
  • [6] CO-INHIBITION OF p110α AND p110β IS REQUIRED FOR SUSTAINED PI3K SUPPRESSION
    不详
    [J]. CANCER DISCOVERY, 2015, 5 (02) : 105 - 105
  • [7] Pharmacological inhibition of p110δ subunit of PI3K confers protection against experimental leishmaniasis
    Khadem, Forough
    Jia, Ping
    Mou, Zhirong
    Barazandeh, Aida Feiz
    Liu, Dong
    Keynan, Yoav
    Uzonna, Jude E.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (02) : 467 - 477
  • [8] CircDiaph3 influences PASMC apoptosis by regulating PI3K/AKT/mTOR pathway through IGF1R
    Ge Liu
    Shengqiang Zhang
    Shaofeng Yang
    Chongwen Shen
    Chao Shi
    Wenjie Diao
    [J]. 3 Biotech, 2023, 13
  • [9] CircDiaph3 influences PASMC apoptosis by regulating PI3K/AKT/mTOR pathway through IGF1R
    Liu, Ge
    Zhang, Shengqiang
    Yang, Shaofeng
    Shen, Chongwen
    Shi, Chao
    Diao, Wenjie
    [J]. 3 BIOTECH, 2023, 13 (10)
  • [10] Enhanced Akt phosphorylation and myogenic differentiation in PI3K p110β-deficient myoblasts is mediated by PI3K p110α and mTORC2
    Matheny, Ronald W., Jr.
    Lynch, Christine M.
    Leandry, Luis A.
    [J]. GROWTH FACTORS, 2012, 30 (06) : 367 - 384
12345